Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: A report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry

Barak Zafrir, Lars H. Lund, Cecile Laroche, Frank Ruschitzka, Maria G. Crespo-Leiro, Andrew J.S. Coats, Stefan D. Anker, Gerasimos Filippatos, Petar M. Seferovic, Aldo P. Maggioni, Manuel De Mora Martin, Lech Polonski, Jose Silva-Cardoso, Offer Amir

Research output: Contribution to journalArticlepeer-review

228 Scopus citations

Abstract

To investigate the characteristics long-Term prognostic implications (up to ∼2.2 years) of atrial fibrillation (AF) compared to sinus rhythm (SR), between acute and chronic heart failure (HF) with reduced (HFrEF < 40%), midrange (HFmrEF 40-49%), and preserved (HFpEF ≤ 50%) ejection fraction (EF). Methods and results Data from the observational, prospective, HF long-Term registry of the European Society of Cardiology were analysed. A total of 14 964 HF patients (age 66 ± 13 years, 67% male; 53% HFrEF, 21% HFmrEF, 26% HFpEF) were enrolled. The prevalence of AF was 27% in HFrEF, 29% in HFmrEF, and 39% in HFpEF. Atrial fibrillation was associated with older age, lower functional capacity, and heightened physical signs of HF. Crude rates of mortality and HF hospitalization were higher in patients with AF compared to SR, in each EF subtype. After multivariable adjustment, the hazard ratio of AF for HF hospitalizations was: 1.036 (95% CI 0.888-1.208, P = 0.652) in HFrEF, 1.430 (95% CI 1.087-1.882, P = 0.011) in HFmrEF, and 1.487 (95% CI 1.195-1.851, P < 0.001) in HFpEF; and for combined all-cause death or HF hospitalizations: 0.957 (95% CI 0.843-1.087, P = 0.502), 1.302 (95% CI 1.055-1.608, P = 0.014), and 1.365 (95% CI 1.152-1.619, P < 0.001), respectively. In patients with HFrEF, AF was not associated with worse outcomes in those presenting with either an acute or a chronic presentation of HF.

Original languageEnglish
Pages (from-to)4277-4284
Number of pages8
JournalEuropean Heart Journal
Volume39
Issue number48
DOIs
StatePublished - 21 Dec 2018

Bibliographical note

Publisher Copyright:
© Oxford University Press. All rights reserved.

Funding

1Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel; 2Heart and Vascular Theme, Karolinska University Hospital, Stockholm; 3Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 4EURObservational Research Programme, European Society of Cardiology, Sophia-Antipolis, France; 5Heart Failure and Transplantation Clinic, University Hospital Zurich, Zurich, Switzerland; 6Unidad de Insuficiencia Cardiaca y Trasplante Cardiaco, Complexo Hospitalario Universitario A Coruna (CHUAC), INIBIC, UDC, CIBERCV, La Coruna, Spain; 7IRCCS, San Raffaele, Pisana, Rome, Italy; 8Division of Cardiology and Metabolism, Department of Cardiology (CVK), Berlin-Brandenburg Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Germany; 9Department of Cardiology and Pneumology, University Medicine Göttingen (UMG), Göttingen, Germany; 10Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece; 11Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia; 12ANMCO Research Center, Florence, Italy; 13Department of Cardiology, Hospital Regional Universitario Carlos Haya, Malaga, Spain; 14Slaskie Centrum Chorob Serca, Zabrze, Poland; 15Department of Cardiology, Faculty of Medicine of Porto University, Hospital de Sao Joao, Porto, Portugal; 16Department of Cardiovascular Medicine, Poriya Medical Center, Tiberius, Israel; and 17The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Safed 1311502, Israel

FundersFunder number
Berlin-Brandenburg Center for Regenerative Therapies
Clinical Centre of Serbia, Belgrade, Serbia
Karolinska University Hospital
Deutsches Zentrum für Herz-Kreislaufforschung
Breast Cancer Research Trust
Bar-Ilan University
Karolinska Institutet7IRCCS
Faculty of Medicine, Assiut University

    Keywords

    • Ejection fraction

    Fingerprint

    Dive into the research topics of 'Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: A report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry'. Together they form a unique fingerprint.

    Cite this